Depression as prognostic indicator of survival, nutritional status in head and neck cancer
the ONA take:
Presence of depression can have a significant impact on patient quality of life and treatment outcomes. This study evaluated the association between presence of pretreatment depression and pretreatment quality of life (QOL), nutritional status, and survival outcomes in patients with head and neck squamous cell carcinoma (HNSCC).
The researchers enrolled 241 patients with previously untreated HNSCC who underwent curative treatments. The Beck Depression Inventory (BDI)-II was used to determine depressive (score ≥14) vs. nondepressive (score <14) patients.
Participants also completed the European Organization for Research and Treatment of Cancer (EORTC) 30-item Core QOL Questionnaire (QLQ-C30) and the EORTC QLQ Head and Neck module (QLQ-H&N35).
Univariate and multivariate analyses were used to assess whether presence of depression was associated with overall survival, disease-free survival (DFS), or posttreatment changes in nutritional status and laboratory data.
Pretreatment depression was present in 60 patients. Study findings showed 3-year overall survival rates, 3-year DFS rates, and pretreatment serum albumin levels were lower in the depressive patients.
EORTC QLQ-C30 and QLQ-H&N35 scores differed between depressive and nondepressive patients on all items except feeding tube, nutritional supplement, and problem with mouth opening.
The researchers conclude that pretreatment depression has a significant impact on pretreatment QOL, nutritional status, and survival outcomes in patients with HNSCC.
Presence of depression can have a significant impact on patient quality of life and treatment outcomes.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|